Alison L. Hannah Cytom X Therapeutics, Inc. (CTMX) insider trading activity

CTMX Quotes by TradingView

Alison L. Hannah is Chief Medical Officer of CytomX Therapeutics, Inc.. Currently has a direct ownership of 31,898 shares of CTMX, which is worth approximately $109,410. The most recent transaction as insider was on Jul 20, 2022, when has been sold 5,602 shares (Common Stock) at a price of $1.42 per share, resulting in proceeds of $7,955. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.9K
0% 3M change
0% 12M change
Total Value Held $109,410

ALISON L. HANNAH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 20 2022
SELL
Open market or private sale
$7,955 $1.42 p/Share
5,602 Reduced 14.94%
31,898 Common Stock
Jul 19 2022
BUY
Grant, award, or other acquisition
-
15,000 Added 28.57%
37,500 Common Stock
Feb 02 2022
BUY
Grant, award, or other acquisition
-
22,500 Added 50.0%
22,500 Common Stock

Also insider at

RIGL
RIGEL PHARMACEUTICALS INC Healthcare
NEO
NEOGENOMICS INC Healthcare
Director
ALH

Alison L. Hannah

Chief Medical Officer
South San Francisco, CA

Track Institutional and Insider Activities on CTMX

Follow CytomX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTMX shares.

Notify only if

Insider Trading

Get notified when an Cytom X Therapeutics, Inc. insider buys or sells CTMX shares.

Notify only if

News

Receive news related to CytomX Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTMX